Skip to content
TrialScanner

NCT04789174

Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study

Phase 4CompletedAXSMLead

Registry record

Lead sponsor
Axsome Therapeutics, Inc.
Conditions
Excessive Daytime Sleepiness; Obstructive Sleep Apnea; Impaired Cognitive Function
Primary completion
Sep 19, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04789174 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04789174: Solriamfetol's Effect on... | TrialScanner